
Nesidioblastosis in the adult: A case report
Author(s) -
Luis Ricardo Ramírez-González,
Jorge Arturo Sotelo-Álvarez,
Priscila Rojas-Rubio,
Michel Dassaejv Macías-Amezcua,
Rafael Orozco-Rubio,
Clotilde Fuentes-Orozco
Publication year - 2015
Publication title -
cirugía y cirujanos
Language(s) - English
Resource type - Journals
ISSN - 2444-0507
DOI - 10.1016/j.circen.2015.09.006
Subject(s) - nesidioblastosis , insulinoma , medicine , hyperinsulinemic hypoglycemia , pancreas , gastroenterology , hypoglycemia , hyperinsulinism , chromogranin a , malignancy , endocrinology , pathology , insulin , immunohistochemistry , insulin resistance
BackgroundNesidioblastosis is a rare cause of endocrine disease which represents between 0.5% and 5% of cases. This has been associated with other conditions, such as in patients previously treated with insulin or sulfonylurea, in anti-tumour activity in pancreatic tissue of patients with insulinoma, and in patients with other tumours of the Langerhans islet cells. In adults it is presented as a diffuse dysfunction of β cells of unknown cause.Clinical caseThe case concerns 46 year-old female, with a history of Sheehan syndrome of fifteen years of onset, and with repeated events characterised with hypoglycaemia in the last three years. Body scan was performed with octreotide, revealing an insulinoma in the pancreatic region. A distal pancreatectomy was performed on the patient. The study reported a pancreatic fragment 8.5cm×3cm×1.5cm with abnormal proliferation of pancreatic islets in groups of varying size, some of them in relation to the ductal epithelium. Histopathology study was showed positive for chromogranin, confirmed by positive synaptophysin, insulin and glucagon, revealing islet hyperplasia with diffuse nesidioblastosis with negative malignancy. The patient is currently under metabolic control and with no remission of hypoglycaemic events.ConclusionsNesidioblastosis is a disease of difficult diagnosis should be considered in all cases of failure to locate an insulinoma, as this may be presented in up to 4% of persistent hyperinsulinaemic hypoglycaemia